AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35073805 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 228
Study 34423771 — intervention group
Group type: EXPERIMENTAL
Intervention: Theracurmin
Number of subjects: 24
Study 34423771 — intervention group
Group type: COMPARATOR
Intervention: Curcumin powder
Number of subjects: 24
Study 34078975 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O (70%)
Number of subjects: 140
Study 34078975 — intervention group
Group type: COMPARATOR
Intervention: Air (70%)
Number of subjects: 140
Study 32094333 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress induction (socially evaluated cold‐pressor test)
Number of subjects: 46
Study 32094333 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional connectivity assessment of the caudate nucleus and posterior putamen
Number of subjects: 46
Study 32094333 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional connectivity assessment of the posterior putamen
Number of subjects: 46
Study 32247304 — intervention group
Group type: COMPARATOR
Intervention: Omalizumab
Number of subjects: 0
Study 33589406 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenyankangfu Tablet (SYKFT)
Number of subjects: 735
Study 33589406 — intervention group
Group type: COMPARATOR
Intervention: Losartan potassium 50 mg
Number of subjects: 735
Study 33589406 — intervention group
Group type: EXPERIMENTAL
Intervention: SYKFT plus losartan potassium 50 mg
Number of subjects: 735
Study 33589406 — intervention group
Group type: EXPERIMENTAL
Intervention: SYKFT plus losartan potassium 100 mg
Number of subjects: 735
Study 33589406 — intervention group
Group type: EXPERIMENTAL
Intervention: SYKFT
Number of subjects: 735
Study 33589406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SYKFT)
Number of subjects: 735
Study 32176112 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1g in 100mL saline solution applied for 5 minutes before wound closure
Number of subjects: 0
Study 32176112 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0
Study 32176112 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 0
Study 34890045 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based genetic education intervention
Number of subjects: 594
Study 34890045 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 594
Study 34300291 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific rehabilitation protocol supervised by a physiotherapist
Number of subjects: 90
Study 34300291 — intervention group
Group type: COMPARATOR
Intervention: General post-surgical treatment protocol
Number of subjects: 90
Study 32564657 — intervention group
Group type: EXPERIMENTAL
Intervention: Lachnospiraceae enriched cluster
Number of subjects: 130
Study 32564657 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterobacteriaceae enriched cluster
Number of subjects: 130
Study 33482440 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (diet, exercise, and behavioral changes)
Number of subjects: 875
Study 33482440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 875
Study 32111517 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-m corridor
Number of subjects: 90
Study 32111517 — intervention group
Group type: COMPARATOR
Intervention: 15-m corridor
Number of subjects: 90
Study 36151526 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on Health Belief Model (HBM)
Number of subjects: 120
Study 36151526 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 34103518 — intervention group
Group type: COMPARATOR
Intervention: alpha1‐oleate
Number of subjects: 0
Study 32375676 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling Intervention (PACI)
Number of subjects: 13
Study 32375676 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 13
Study 35902534 — intervention group
Group type: EXPERIMENTAL
Intervention: EPTPassive
Number of subjects: 30
Study 35902534 — intervention group
Group type: EXPERIMENTAL
Intervention: EPTActive
Number of subjects: 30
Study 35902534 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 36040740 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based education for nurses delivered over 18 months (8 months active education + 10 months maintenance)
Number of subjects: 8349
Study 36040740 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 8349
Study 36040740 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based education for nurses
Number of subjects: 8349
Study 33378108 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (electroacupuncture at Hegu point (LI4) and Zusanli point (ST36) and auricular-point pressure on Shenmen point)
Number of subjects: 50
Study 33378108 — intervention group
Group type: COMPARATOR
Intervention: Single therapy (only auricular-point pressure)
Number of subjects: 50
Study 33378108 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 50
Study 33721566 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal HIV testing and treatment (UTT) via home-based HIV counselling and testing, linkage to care, promotion of ART adherence, and voluntary medical male circumcision.
Number of subjects: 341323
Study 32443934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy
Number of subjects: 50
Study 32443934 — intervention group
Group type: COMPARATOR
Intervention: Dose-dense chemotherapy
Number of subjects: 50
Study 33219678 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ACHD
Number of subjects: 17189
Study 33219678 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 17189
Study 32066407 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-benefit message
Number of subjects: 222
Study 32066407 — intervention group
Group type: COMPARATOR
Intervention: Social-benefit message
Number of subjects: 222
Study 32066407 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-benefit message among high-risk perceiving patients
Number of subjects: 222
Study 32066407 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-benefit message among low-risk perceiving patients
Number of subjects: 222
Study 33181779 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational medicine intervention
Number of subjects: 305
Study 33181779 — intervention group
Group type: COMPARATOR
Intervention: Clinical care alone
Number of subjects: 305
Study 33045502 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketonuria (measured at hospital admission)
Number of subjects: 215
Study 36385041 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression by elastic bandage on the affected knee, once a day for 20 min, on four consecutive days
Number of subjects: 90
Study 36385041 — intervention group
Group type: COMPARATOR
Intervention: Sham (elastic band placed around the affected knee without compression)
Number of subjects: 90
Study 36385041 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 90
Study 36385041 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression by elastic bandage
Number of subjects: 90
Study 36385041 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 90
Study 36385041 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 34373384 — intervention group
Group type: EXPERIMENTAL
Intervention: DKT therapy group (TJ-100 administration for 14 days postoperatively or until discharge)
Number of subjects: 0
Study 34373384 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (no administration of DKT)
Number of subjects: 0
Study 34373384 — intervention group
Group type: EXPERIMENTAL
Intervention: DKT therapy group
Number of subjects: 0
Study 34373384 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study 32402650 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study 36209035 — intervention group
Group type: EXPERIMENTAL
Intervention: PharmNet intervention
Number of subjects: 0
Study 33459698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping therapy with 45 mm cup
Number of subjects: 12
Study 33459698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping therapy with 35 mm cup
Number of subjects: 12
Study 32317371 — intervention group
Group type: EXPERIMENTAL
Intervention: Surpass Evolve (Stryker)
Number of subjects: 8
Study 32317371 — intervention group
Group type: COMPARATOR
Intervention: Pipeline Flex (Medtronic)
Number of subjects: 8
Study 36414963 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Management Training (PMT)
Number of subjects: 270
Study 36414963 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Violent Resistance Training (NVR)
Number of subjects: 270
Study 36414963 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 270
Study 32221707 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) treatment during arm immobilization (5 sessions of 15 min every two hours)
Number of subjects: 14
Study 32221707 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) treatment during arm immobilization
Number of subjects: 14
Study 32221707 — intervention group
Group type: COMPARATOR
Intervention: Arm immobilization without MI treatment
Number of subjects: 14
Study 34652862 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher carbohydrate bedtime snack
Number of subjects: 68
Study 34652862 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower carbohydrate bedtime snack
Number of subjects: 68
Study 34652862 — intervention group
Group type: COMPARATOR
Intervention: No bedtime snack
Number of subjects: 68
Study 33254237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) using a pressure of 20 cmH2O for 15 seconds followed by nasal continuous positive airway pressure (CPAP) of 5 cmH2O
Number of subjects: 160
Study 33254237 — intervention group
Group type: COMPARATOR
Intervention: Nasal CPAP alone
Number of subjects: 160
Study 33254237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) in sicker infants (clinical eligibility criteria)
Number of subjects: 160
Study 33254237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) in smaller babies (GA <30 weeks)
Number of subjects: 160
Study 32310966 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (MDA) for STH
Number of subjects: 104
Study 32310966 — intervention group
Group type: COMPARATOR
Intervention: School-based deworming
Number of subjects: 104
Study 32683735 — intervention group
Group type: EXPERIMENTAL
Intervention: Grid RF
Number of subjects: 8
Study 32683735 — intervention group
Group type: COMPARATOR
Intervention: Laser Genesis
Number of subjects: 8
Study 34649553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health education intervention (OHE) given at baseline, third and sixth months
Number of subjects: 240
Study 34649553 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention until after the study)
Number of subjects: 240
Study 33060089 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib plus venetoclax (IV) for 12 cycles after a short induction with ibrutinib
Number of subjects: 0
Study 33060089 — intervention group
Group type: COMPARATOR
Intervention: Continue ibrutinib after reaching undetectable minimal residual disease (uMRD)
Number of subjects: 0
Study 33060089 — intervention group
Group type: COMPARATOR
Intervention: Stop ibrutinib after reaching undetectable minimal residual disease (uMRD)
Number of subjects: 0
Study 33060089 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinitiate IV treatment in patients who become positive for MRD again after stopping
Number of subjects: 0
Study 35224881 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy, systems and environmental change (PSE) strategies to promote responsive bottle-feeding
Number of subjects: 0
Study 35224881 — intervention group
Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 0
Study 34755800 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nursing program (spatial and temporal guidance, visual stimulus, auditive stimulus, family support)
Number of subjects: 81
Study 34755800 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study 34755800 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nursing program
Number of subjects: 81
Study 32768588 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + multiple PDT
Number of subjects: 33
Study 32768588 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 33
Study 35988664 — intervention group
Group type: EXPERIMENTAL
Intervention: artemisinin-piperaquine (AP)
Number of subjects: 238
Study 35988664 — intervention group
Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 238
Study 32770240 — intervention group
Group type: EXPERIMENTAL
Intervention: AVIFAVIR (favipiravir)
Number of subjects: 0
Study 32770240 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35932158 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid mixture (nine essential amino acids)
Number of subjects: 36
Study 35932158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 34890837 — intervention group
Group type: EXPERIMENTAL
Intervention: Helping relationships intervention strategies provided to significant others for 12 months
Number of subjects: 120
Study 34890837 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 34431624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifflin-St-Jeor equation
Number of subjects: 66
Study 34431624 — intervention group
Group type: EXPERIMENTAL
Intervention: Harris-Benedict equation
Number of subjects: 66
Study 34431624 — intervention group
Group type: EXPERIMENTAL
Intervention: Owen equation
Number of subjects: 66
Study 34431624 — intervention group
Group type: EXPERIMENTAL
Intervention: World Health Organization/Food and Agriculture equation
Number of subjects: 66
Study 34075713 — intervention group
Group type: EXPERIMENTAL
Intervention: High activity level group (HA group)
Number of subjects: 22
Study 34075713 — intervention group
Group type: COMPARATOR
Intervention: Low activity level group (LA group)
Number of subjects: 22
Study 34217297 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG administered over 12 hours (12H group)
Number of subjects: 39
Study 34217297 — intervention group
Group type: COMPARATOR
Intervention: IVIG administered over 24 hours (24H group)
Number of subjects: 39
Study 35136598 — intervention group
Group type: EXPERIMENTAL
Intervention: Online professional development course about responsive caregiving
Number of subjects: 181
Study 35136598 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 181
Study 34872087 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 132
Study 34872087 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia + Circadian Rhythm Support (CBT-I+CRS)
Number of subjects: 132
Study 34872087 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 132
Study 32432795 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Training (2-hour workshop + 4 weeks of guided self-practice)
Number of subjects: 224
Study 32432795 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 224
Study 33939347 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamine + Probiotic (LactoCare)
Number of subjects: 42
Study 33939347 — intervention group
Group type: COMPARATOR
Intervention: Antihistamine (Control)
Number of subjects: 42
Study 36090831 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based malaria testing
Number of subjects: 5756
Study 36090831 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing positive for malaria
Number of subjects: 5756
Study 36090831 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing negative for malaria
Number of subjects: 5756
Study 36090831 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria-negative participants
Number of subjects: 5756
Study 34075879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing (mean percentage of days with self-weighing: 39.98%, equivalent to 2.8 self-weighs per week)
Number of subjects: 9768
Study 34075879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing (during breaks of ≥30 days without weight measurements)
Number of subjects: 9768
Study 32801436 — intervention group
Group type: COMPARATOR
Intervention: EECP Therapy
Number of subjects: 88
Study 32801436 — intervention group
Group type: EXPERIMENTAL
Intervention: TMZ 35 mg twice daily + EECP Therapy
Number of subjects: 88
Study 33896356 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg/2 mL pre-filled syringe
Number of subjects: 214
Study 33896356 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Injection Assessment Questionnaire (SIAQ)
Number of subjects: 214
Study 33896356 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions for Use (IFU)
Number of subjects: 214
Study 32258131 — intervention group
Group type: EXPERIMENTAL
Intervention: Uric acid levels (measured as standard deviation increase)
Number of subjects: 1381
Study 32258131 — intervention group
Group type: EXPERIMENTAL
Intervention: Uric acid levels (unadjusted and adjusted analyses)
Number of subjects: 1381
Study 32258131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using variation at rs11722228 (SLC2A9) as an instrument for uric acid
Number of subjects: 1381
Study 35815886 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal total mesorectal resection (taTME)
Number of subjects: 1115
Study 35815886 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic total mesorectal excision (laTME)
Number of subjects: 1115
Study 33422022 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-child interaction
Number of subjects: 30
Study 33422022 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to books and complex toys
Number of subjects: 30
Study 33422022 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing to children
Number of subjects: 30
Study 33422022 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived learning value of activities
Number of subjects: 30
Study 33422022 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of songs for promoting ECD
Number of subjects: 30
Study 32318781 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R2) program
Number of subjects: 213
Study 32318781 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 213
Study 35092972 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional opioid general anesthesia (group A)
Number of subjects: 123
Study 35092972 — intervention group
Group type: COMPARATOR
Intervention: Reducing-opioids general anesthesia (group B)
Number of subjects: 123
Study 34471708 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology interventions (PPI) - 10 weekly training sessions
Number of subjects: 40
Study 34471708 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care (Control)
Number of subjects: 40
Study 34471708 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology interventions (PPI)
Number of subjects: 40
Study 32087338 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance‐Only
Number of subjects: 0
Study 32087338 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight‐Loss Only
Number of subjects: 0
Study 32087338 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Attendance and Weight‐Loss
Number of subjects: 0
Study 32087338 — intervention group
Group type: COMPARATOR
Intervention: Control (no incentives)
Number of subjects: 0
Study 33461829 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring and Treatment Referral (MTR)
Number of subjects: 750
Study 33461829 — intervention group
Group type: EXPERIMENTAL
Intervention: quarterly RMC (RMC‐Q)
Number of subjects: 750
Study 33461829 — intervention group
Group type: EXPERIMENTAL
Intervention: RMC‐A
Number of subjects: 750
Study 33461829 — intervention group
Group type: COMPARATOR
Intervention: RMC‐Q/RMC‐A
Number of subjects: 750
Study 33461829 — intervention group
Group type: COMPARATOR
Intervention: MTR vs. RMC‐Q vs. RMC‐A
Number of subjects: 750
Study 32244111 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0
Study 32244111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36167851 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out protocol for antibiotic de-escalation
Number of subjects: 767
Study 36167851 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 767
Study 34190191 — intervention group
Group type: EXPERIMENTAL
Intervention: GCWB106 for 12 weeks
Number of subjects: 121
Study 34190191 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 121
Study 33078727 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg and amoxicillin 1 g bid during the early half of treatment, followed by esomeprazole 40 mg with levofloxacin 500 mg and tinidazole 500 mg bid during the second half of treatment (Group A)
Number of subjects: 186
Study 33078727 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg and amoxicillin 1 g bid during the early half of treatment, followed by esomeprazole 40 mg with clarithromycin 500 mg bid during the second half of treatment (Group B)
Number of subjects: 186
Study 35320121 — intervention group
Group type: EXPERIMENTAL
Intervention: PPC training + EPC
Number of subjects: 360
Study 35320121 — intervention group
Group type: EXPERIMENTAL
Intervention: PPC training + SOC
Number of subjects: 360
Study 35320121 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 360
Study 35331179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality functioning dimensions (Identity integration)
Number of subjects: 138
Study 35331179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality trait dimensions (Disinhibition)
Number of subjects: 138
Study 35331179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality trait dimensions (Negative affect)
Number of subjects: 138